Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

HELX

Franklin Genomic Advancements ETF

May 02 • 09:32AM ET

30.58

Dollar change +0.00
Percentage change 0.01	%

Financial • Exchange Traded Fund • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	1.68%	Shs Outstand		Perf Week	2.11%
Sponsor	Franklin Templeton	ETF Type		Tags	equity	Return% 3Y	-12.94%	Total Holdings	66	Perf Month	-4.58%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	AUM	9.02M	Perf Quarter	1.23%
Index	-	Average Maturity		Tags	genomics	Return% 10Y		NAV%		Perf Half Y	19.97%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	2.66%
Active/Passive		Quant Type		Tags	-	Flows% 1M	0.00%	52W Range	25.26 - 32.92	Perf YTD	0.37%
Dividend TTM	-	ESG Type		Tags	-	Flows% 3M	0.00%	52W High	-7.10%	Beta	1.06
Dividend Ex-Date	Dec 30, 2021	Dividend Type		Sector/Theme		Flows% YTD	-14.27%	52W Low	21.07%	ATR (14)	0.36
Expense	0.50%	Structure Type		Region		Flows% 1Y		RSI (14)	46.10	Volatility	0.49% 0.48%
Option/Short	Yes / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	2.01	Prev Close	30.58
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	0.85K	Price	30.58
SMA20	-0.63%	SMA50	-3.74%	SMA200	2.51%	Trades		Volume	177	Change	0.01%

Jul-16-21 11:19AM	Blockchain will be hugely disruptive to the finance industry: Jenny Johnson (Yahoo Finance Video)
Jan-14-21 09:15AM	Franklin Adds To Thematic ETF Line (ETF.com)
Oct-05-20 08:00AM	Franklin Templeton Gives Matt Moberg Three New Funds To Run (Investor's Business Daily)

Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

open in yahoo | open in marketwatch | open in google

HELX

Franklin Genomic Advancements ETF

Upgrade your FINVIZ experience